A single nucleotide polymorphism in the promoter region of let-7 family is associated with lung cancer risk in Chinese

Genetics and Molecular Research

Volumn 14, Issue 2, 2015, Pages 4504-4512

  Shen, L Q ^a   Xie, Y Z ^a   Qian, X F ^b   Zhuang, Z X ^a   Jiao, Y ^c   Qi, X F ^b,d  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Let 7; Lung cancer; Single nucleotide polymorphism; Susceptibility

Indexed keywords

MICRORNA; MICRORNA LET 7; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, HUMAN;

ADULT; AGE; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK ASSESSMENT; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; MULTIGENE FAMILY; RISK FACTOR; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84929467928     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.May.4.8     Document Type: Article

References (32)

1. Boyerinas B, Park SM, Hau A, Murmann AE, et al. (2010). The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 17: F19-F36.
2. Brueckner B, Stresemann C, Kuner R, Mund C, et al. (2007). The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67: 1419-1423.
3. Campayo M, Navarro A, Viñolas N, Tejero R, et al. (2011). A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One 6: e22509.
4. Chen YB, Mu CY, Chen C, Huang JA, et al. (2014). Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population. Asia Pac. J. Clin. Oncol. 10:e1-6.
5. Chin LJ, Ratner E, Leng S, Zhai R, et al. (2008). A SNP in a let-7 microRNA complementary site in the KRAS 3'-untranslated region increases non-small cell lung cancer risk. Cancer Res. 68: 8535-8540.
6. Christensen BC, Moyer BJ, Avissar M, Ouellet LG, et al. (2009). A let-7 microRNA-binding site polymorphism in the KRAS 3'UTR is associated with reduced survival in oral cancers. Carcinogenesis 30: 1003-1007.
7. Ding C, Li R, Peng J, Li S, et al. (2012). A polymorphism at the miR-502 binding site in the 3'-untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp. Ther. Med. 3: 689-692.
8. Ding C, Li C, Wang H, Li B, et al. (2013). A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer. Onco. Targets Ther. 6: 877-881.
9. Hu Z, Chen J, Tian T, Zhou X, et al. (2008). Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118: 2600-2608.
10. Huang F, Hu LM, Liu JB, Zhang YX, et al. (2011). Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma. Zhonghua Yu Fang. Yi Xue Za. Zhi. 45: 1093-1098.
11. Kumar MS, Erkeland SJ, Pester RE, Chen CY, et al. (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA 105: 3903-3908.
12. Lewis BP, Burge CB and Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
13. Lim LP, Lau NC, Garrett-Engele P, Grimson A, et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
14. Lu Y, Lu J, Liu Q, Niu J, et al. (2013). A c.464 T>A mutation in VHL gene in a Chinese family with VHL syndrome. J. Neurooncol. 111: 313-318.
15. Paranjape T, Heneghan H, Lindner R, Keane FK, et al. (2011). A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol. 12: 377-386.
16. Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, et al. (2011). The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin. Cancer Res. 17: 3742-3750.
17. Raponi M, Dossey L, Jatkoe T, Wu X, et al. (2009). MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69: 5776-5783.
18. Shastry BS (2009). SNPs: impact on gene function and phenotype. Methods Mol. Biol. 578: 3-22.
19. Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876.
20. Siegel R, Naishadham D and Jemal A (2013). Cancer statistics, 2013. CA Cancer J. Clin. 63: 11-30.
21. Smits KM, Paranjape T, Nallur S, Wouters KA, et al. (2011). A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. Clin. Cancer Res. 17: 7723-7731.
22. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64: 3753-3756.
23. Tian T, Shu Y, Chen J, Hu Z, et al. (2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18: 1183-1187.
24. Xie K, Liu J, Zhu L, Liu Y, et al. (2013). A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma. Cancer Epidemiol. 37: 998-1002.
25. Xie X, Lu J, Kulbokas EJ, Golub TR, et al. (2005). Systematic discovery of regulatory motifs in human promoters and 3'UTRs by comparison of several mammals. Nature 434: 338-345.
26. Xu J, Yin Z, Gao W, Liu L, et al. (2013a). Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One 8: e77024.
27. Xu J, Yin Z, Shen H, Gao W, et al. (2013b). A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One 8: e79135.
28. Yanaihara N, Caplen N, Bowman E, Seike M, et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
29. Yang Y, Li X, Yang Q, Wang X, et al. (2010). The role of microRNA in human lung squamous cell carcinoma. Cancer Genet. Cytogenet. 200:127-133.
30. Zhan M, Qu Q, Wang G, Liu YZ, et al. (2013). let-7c inhibits NSCLC cell proliferation by targeting HOXA1. Asian Pac. J. Cancer Prev. 14: 387-392.
31. Zhong Z, Dong Z, Yang L, Chen X, et al. (2012). Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp. Ther. Med. 4: 267-272.
32. Zu Y, Ban J, Xia Z, Wang J, et al. (2013). Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. Biochem. Biophys. Res. Commun. 430: 529-534.